A neutral study on biocon & sme untold or unheard truths in last slide abt ms.shaw

1. THE BIOCON STORY

3. Products include: Biopharmaceuticals Anti-Diabetic Agents Anti-Hypertensive Agents Anti-Inflammatory Agents Antioxidants Cardiovascular Agents Digestive Aid Enzymes Haemostatic Agents Hepatoprotective Agents Immunosuppressants Nutraceuticals Enzymes Amylases Cellulases Esterases Glucanases Hemicellulases/Xylanases Oxidases Pectinases Proteases Tannase

10. MILESTONES

11. 2004,Post IPO, became the richest Indian woman (U.S $ 480 million) I978, started Biocon India Ltd. in collaboration with Biocon Int. 1990s, Unilever collaboration & Plafractor technology 1998, Biocon became a separate identity by buying Unilever share. 1996, got into Biopharmaceuticals & statins

18. Recognition: Padma Bhushan (2005) The Economic Times Business Woman of the Year Award (2004) Ernst & Young Entrepreneur of the Year Award in Healthcare & Life Sciences (2002) Padma Shri (1989) Outstanding Young Person Award by Jaycees (1987) Rotary award for the Best Model Employer (1983) Outstanding Contribution Award (AWAKE) (1983) Gold for Best Woman Entrepreneur , Institute of Marketing Management (1982) Positions Held: Chairperson and Mission Leader of CII's National Task Force on Biotechnology Member, Board of Science Foundation, Ireland Member, Board of Governors, IIM Bangalore Chairperson, Karnataka's Vision Group on Biotechnology Vice-President, Association of Women Entrepreneurs of Karnataka (AWAKE)

19. "If I can build a company like Biocon, anyone can… The first step was to dream however big or small…. If you have a vision, no matter how big or small, a plan, no matter if it is imperfect, but if there is passion and conviction for it, success is inevitable." - Kiran Mazumdar Shaw, Managing Director, Biocon India Limited.

21. THANK YOU